Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
High-Risk Populations for Severe Pneumococcal Infection
Key opinion leaders identify high-risk populations for invasive pneumococcal disease, explain the underlying factors contributing to their increased susceptibility, and offer strategies to improve suboptimal vaccination rates, particularly among historically underserved communities.
EP: 1.Symptomatology and Transmission of Pneumococcal Infection
EP: 2.Manifestation of Pneumococcal Disease in Adults
Now Viewing
EP: 3.High-Risk Populations for Severe Pneumococcal Infection
EP: 4.Patient Burden Associated with Pneumococcal Disease
EP: 5.Vaccination Efforts to Mitigate Pneumococcal Outbreaks
EP: 6.Comparing and Contrasting the Characteristics of the FDA-Approved Pneumococcal Vaccines
EP: 7.Target Patient Populations for Pneumococcal Vaccines
EP: 8.ACIP Recommendations for Pneumococcal Vaccination
EP: 9.Clinical Considerations for Pneumococcal Vaccination Scheduling
EP: 10.Clinical Data Supporting Pneumococcal Vaccination
- Who are the high-risk populations for developing invasive pneumococcal disease?
- What is the rationale for why certain populations are at risk for severe pneumococcal infections?
- How can we improve inadequate pneumococcal vaccine uptake rates, specifically in historically marginalized groups?
Recent Videos
Related Content
